Liver and kidney

Prepared by treating 1,3-dibromopropane with zinc. It is a powerful gaseous anaesthetic, non-irritant and non-toxic to the liver and kidneys, but it is a respiratory depressant. 

Materials may be absorbed by a variety of mechanisms. Depending on the nature of the material and the site of absorption, there may be passive diffusion, filtration processes, faciHtated diffusion, active transport and the formation of microvesicles for the cell membrane (pinocytosis) (61). EoUowing absorption, materials are transported in the circulation either free or bound to constituents such as plasma proteins or blood cells. The degree of binding of the absorbed material may influence the availabiHty of the material to tissue, or limit its elimination from the body (excretion). After passing from plasma to tissues, materials may have a variety of effects and fates, including no effect on the tissue, production of injury, biochemical conversion (metaboli2ed or biotransformed), or excretion (eg, from liver and kidney). 

An acute lethal dose (LC q) for vapor exposure to 1,1,2-trichloroethane in the rat is 2000 ppm for a 4-h exposure. The same lethal effect occurs at 18,000 ppm vapor during 3 h exposure to 1,1,1-trichloroethane. The oral LD q for 1,1,2-trichloroethane in rats is 0.1—0.2 g/kg, classifying it as moderately toxic (109). Liver and kidney damage occurs at even lower dosages. Skin adsorption is a possible route of overexposure. 

The vapors of aHyl chloride are very irritating to the eyes, nose, and throat. Lung injury may be delayed in onset. Liver and kidney injury can result from exposure to vapors kidney injury is expected to be most severe in acute exposures. High concentrations of vapor can be lethal. FoHowing chronic exposures to the vapors, Hver injury would be expected to occur first (23). 

The absorption, distribution, and accumulation of lead in the human body may be represented by a three-part model (6). The first part consists of red blood cells, which move the lead to the other two parts, soft tissue and bone. The blood cells and soft tissue, represented by the liver and kidney, constitute the mobile part of the lead body burden, which can fluctuate depending on the length of exposure to the pollutant. Lead accumulation over a long period of time occurs in the bones, which store up to 95% of the total body burden. However, the lead in soft tissue represents a potentially greater toxicological hazard and is the more important component of the lead body burden. Lead measured in the urine has been found to be a good index of the amount of mobile lead in the body. The majority of lead is eliminated from the body in the urine and feces, with smaller amounts removed by sweat, hair, and nails. 

Toxicity. Breathing moderate amounts of methyl ethyl ketone (MEK) for short periods of time can cause adverse effects on the nervous system ranging from headaches, dizziness, nausea, and numbness in the fingers and toes to unconsciousness. Its vapors are irritating to the skin, eyes, nose, and throat and can damage the eyes. Repeated exposure to moderate to high amounts may cause liver and kidney effects. 

FIGURE 18.37 (a) Vitamin D3 (cholecalciferol) is produced in the skin by the action of sunlight on 7-dehydrocholesterol. The successive action of mixed-function oxidases in the liver and kidney produces 1,25-dihydroxyvitamin D3, the active form of vitamin D. 

FIGURE 20.2 The organic acids observed by Krebs to be oxidized in suspensions of liver and kidney tissue. These substances were the pieces in the TCA puzzle that Krebs and others eventually solved. 

Nearly All Gluconeogenesis Occurs In the Liver and Kidneys in Animals... 

Glucocorticoids increase the risk of gastrointestinal complications caused by NSAEDs. Considerable caution is necessary when using NSAIDs in patients with severe liver and kidney damage and they should not be combined with coumarines. Owing to the limited experience obtained, these precautions and contraindications also apply to COX-2-selective inhibitors. 

The MAOI antidepressant drag s are contraindicated in patients widi known hypersensitivity to die drug s, liver and kidney disease, cerebrovascular disease, hypertension, or congestive heart failure and in die elderly. These drag s are given cautiously to patients witii impaired liver function, history of seizures, parkinsonian symptoms, diabetes, or hyperthyroidism. 

The observed BCFs for dibutyltin dichloride in round crucian carp (Carassius carassius grandoculis) muscle, vertebra, liver, and kidney tissue were 12, 46,... 

---